Model
Edge
Amylyx Pharmaceuticals Inc.
0001913765
Filing Type
4
Filing Date
4/1/2025
Updated
4/2/25, 3:12 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership